Rachael Harwood

Stock Analyst at Macquarie

(2.82)
# 2,685
Out of 4,356 analysts
59
Total ratings
54.8%
Success rate
3.8%
Average return

Stocks Rated by Rachael Harwood

Integral Diagnostics Limited
Feb 24, 2026
Maintained: Buy
Price Target: $3.40$3.50
Current: $2.17
Upside: +61.29%
Monash IVF Group Limited
Dec 4, 2025
Downgraded: Hold
Price Target: $0.94
Current: $0.71
Upside: +32.39%
Neuren Pharmaceuticals Limited
Nov 10, 2025
Maintained: Buy
Price Target: $21.20
Current: $14.54
Upside: +45.80%
Premier Investments Limited
Mar 13, 2025
Maintained: Hold
Price Target: $29.00$21.60
Current: $12.53
Upside: n/a
PolyNovo Limited
Feb 25, 2025
Maintained: Buy
Price Target: $2.85$2.80
Current: $1.22
Upside: n/a
Nick Scali Limited
Feb 9, 2025
Maintained: Buy
Price Target: $12.60$19.90
Current: $14.43
Upside: n/a
Lovisa Holdings Limited
Nov 18, 2024
Maintained: Buy
Price Target: $26.90$34.10
Current: $23.22
Upside: n/a
Temple & Webster Group Ltd
Nov 30, 2023
Maintained: Hold
Price Target: $6.70$7.45
Current: $5.41
Upside: n/a
Baby Bunting Group Limited
Aug 14, 2023
Maintained: Hold
Price Target: $4.95$2.10
Current: $1.60
Upside: n/a